As of Oct. 21, average U.S. CBD isolate pricing was steady month on month, remaining 3 percent below prices seen in early August and 13 percent below the calendar-year high in January.

To better understand public health issues around CBD and other cannabinoids, FDA recently announced plans to use social media site Reddit and other “novel” sources where users share accounts of first-hand experiences.

While FDA has yet to approve smokable hemp or hemp-infused food and beverages, California Governor Gavin Newson did just that on Oct. 6 when he signed Assembly Bill 45, encouraging hemp CBD demand growth in the state.

Looking at the supply side, licensed U.S. hemp area was 284,793 acres for 2021, down 24 percent YOY. The acreage drop off was expected as prices have not rebounded since 2019/20, when production overwhelmed market demand.

IQ subscribers, log in to see the CBD isolate pricing chart.

Posted by: Information Services
Our Information Services team assists our clients with understanding commodity and ingredient market dynamics. Using our extensive database of intelligence, we also produce regular commodity and commercial market publications covering supply and demand fundamentals, news alerts on events that shape the markets, and resource guides to give you a complete picture of the industries we monitor.